Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Garrison

Showing results (151-160 of 316) with videos related to

Pageof 32
Sort By:
Plos One|April 8, 2015
The short-term cost-effectiveness of once-daily liraglutide versus once-weekly exenatide for the treatment of type 2 diabetes mellitus in the United StatesBruce Wang, Joshua A Roth, Hiep Nguyen, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 11, 2009
Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of miceChristopher M Dekaney, Ajay S Gulati, Aaron P Garrison, et al.
Drug Safety|February 20, 2014
A framework for assessing the economic value of pharmacovigilance in low- and middle-income countriesJoseph B Babigumira, Andy Stergachis, Hye Lyn Choi, et al.
Ecology|November 12, 2021
Modeling abundance, distribution, movement and space use with camera and telemetry dataRichard B Chandler, Daniel A Crawford, Elina P Garrison, et al.
Health Policy (Amsterdam, Netherlands)|March 16, 2010
Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturersJosh J Carlson, Sean D Sullivan, Louis P Garrison, et al.
Journal of Medical Economics|January 24, 2020
Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia AKeziah Cook, Shaun P Forbes, Kelly Adamski, et al.
Pharmacoeconomics|May 8, 2022
Modeling the Ex Ante Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung CancerWoojung Lee, William B Wong, Stacey Kowal, et al.
The Journal of Infectious Diseases|June 14, 2011
Global eradication of measles: an epidemiologic and economic evaluationAnn Levin, Colleen Burgess, Louis P Garrison, et al.
Scientific Reports|April 16, 2021
Cetacean distribution models based on visual and passive acoustic dataKaitlin E Frasier, Lance P Garrison, Melissa S Soldevilla, et al.
Contemporary Clinical Trials|September 18, 2012
The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007)William B Wong, Scott D Ramsey, William E Barlow, et al.
Pageof 32

Showing results (151-160 of 316) with videos related to

Sort By:
Pageof 32
Plos One|April 8, 2015
The short-term cost-effectiveness of once-daily liraglutide versus once-weekly exenatide for the treatment of type 2 diabetes mellitus in the United StatesBruce Wang, Joshua A Roth, Hiep Nguyen, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 11, 2009
Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of miceChristopher M Dekaney, Ajay S Gulati, Aaron P Garrison, et al.
Drug Safety|February 20, 2014
A framework for assessing the economic value of pharmacovigilance in low- and middle-income countriesJoseph B Babigumira, Andy Stergachis, Hye Lyn Choi, et al.
Ecology|November 12, 2021
Modeling abundance, distribution, movement and space use with camera and telemetry dataRichard B Chandler, Daniel A Crawford, Elina P Garrison, et al.
Health Policy (Amsterdam, Netherlands)|March 16, 2010
Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturersJosh J Carlson, Sean D Sullivan, Louis P Garrison, et al.
Journal of Medical Economics|January 24, 2020
Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia AKeziah Cook, Shaun P Forbes, Kelly Adamski, et al.
Pharmacoeconomics|May 8, 2022
Modeling the Ex Ante Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung CancerWoojung Lee, William B Wong, Stacey Kowal, et al.
The Journal of Infectious Diseases|June 14, 2011
Global eradication of measles: an epidemiologic and economic evaluationAnn Levin, Colleen Burgess, Louis P Garrison, et al.
Scientific Reports|April 16, 2021
Cetacean distribution models based on visual and passive acoustic dataKaitlin E Frasier, Lance P Garrison, Melissa S Soldevilla, et al.
Contemporary Clinical Trials|September 18, 2012
The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007)William B Wong, Scott D Ramsey, William E Barlow, et al.
Pageof 32